SIGA Technologies Inc
Cerrado
SectorSanidad
4.3 -0.69
Resumen
Variación precio
24h
Mínimo
4.27
Máximo
4.33
Ingresos | -34M -3.5M |
|---|---|
Ventas | 2.4M 6.2M |
P/B Media del Sector | 15.464 49.052 |
BPA | -0.048 |
Margen de beneficios | -55.334 |
Empleados | 49 |
EBITDA | 4.3M -5.2M |
Próximas Ganancias | 4 ago 2026 |
|---|
Capitalización Mercado | -22M 311M |
|---|---|
Apertura anterior | 4.99 |
Cierre anterior | 4.3 |
Noticias sobre sentimiento de mercado
By Acuity
89%
11%
323 / 342 Clasificación en Healthcare
SIGA Technologies Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
